volume 67 issue 3 pages 562-569

Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction

Publication typeJournal Article
Publication date2018-03-01
scimago Q3
SJR0.305
CiteScore2.8
Impact factor
ISSN10665285, 15739171
General Chemistry
Abstract
Regioselective synthesis of new dispiro indolinones combining both an indolinone and an oxazolone fragment in their structure comprised the 1,3-dipolar cycloaddition of azomethine ylides, generated in situ from isatin and sarcosine, at 2-aryl-5-arylmethylidene-substituted 1,3-oxazol-5(4H)-ones. When ortho and para halogen atoms were present in the aromatic substituents of the starting oxazolones, complex mixtures containing large amounts of oxazoline ring opening products and their dispiro derivatives were formed. The cytotoxicity of compounds was tested by MTT on LNCaP, PC3, HCT116, MCF7, A549, HEK, and VA13 cell lines. The compound possessing the best cytotoxicity revealed the IC50 = 1.08±0.96 μM towards the p53- expressing LNCaP cells and lower activity (IC50 = 3.21±1.45 μM) towards the non-expressing p53 protein PC3 cells, however, it has proved inactive towards the HCT cells, both expressing (HCТ+/+) and non-expressing (HCT–/–) p53.
Found 
Found 

Top-30

Journals

1
2
3
Mendeleev Communications
3 publications, 25%
RSC Advances
2 publications, 16.67%
Chemistry of Heterocyclic Compounds
1 publication, 8.33%
Russian Chemical Bulletin
1 publication, 8.33%
International Journal of Molecular Sciences
1 publication, 8.33%
European Journal of Medicinal Chemistry
1 publication, 8.33%
Tetrahedron Letters
1 publication, 8.33%
Advanced Synthesis and Catalysis
1 publication, 8.33%
Journal of Organic Chemistry
1 publication, 8.33%
1
2
3

Publishers

1
2
3
4
5
Elsevier
5 publications, 41.67%
Royal Society of Chemistry (RSC)
2 publications, 16.67%
Springer Nature
2 publications, 16.67%
MDPI
1 publication, 8.33%
Wiley
1 publication, 8.33%
American Chemical Society (ACS)
1 publication, 8.33%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
12
Share
Cite this
GOST |
Cite this
GOST Copy
Beloglazkina A. А. et al. Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction // Russian Chemical Bulletin. 2018. Vol. 67. No. 3. pp. 562-569.
GOST all authors (up to 50) Copy
Beloglazkina A. А., Skvortsov D. А., Tafeenko V. A., Majouga А. G., Zyk N. V., Beloglazkina Е. К. Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction // Russian Chemical Bulletin. 2018. Vol. 67. No. 3. pp. 562-569.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s11172-018-2111-x
UR - https://doi.org/10.1007/s11172-018-2111-x
TI - Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction
T2 - Russian Chemical Bulletin
AU - Beloglazkina, A А
AU - Skvortsov, D А
AU - Tafeenko, V. A.
AU - Majouga, А G
AU - Zyk, N. V.
AU - Beloglazkina, Е К
PY - 2018
DA - 2018/03/01
PB - Springer Nature
SP - 562-569
IS - 3
VL - 67
SN - 1066-5285
SN - 1573-9171
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2018_Beloglazkina,
author = {A А Beloglazkina and D А Skvortsov and V. A. Tafeenko and А G Majouga and N. V. Zyk and Е К Beloglazkina},
title = {Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction},
journal = {Russian Chemical Bulletin},
year = {2018},
volume = {67},
publisher = {Springer Nature},
month = {mar},
url = {https://doi.org/10.1007/s11172-018-2111-x},
number = {3},
pages = {562--569},
doi = {10.1007/s11172-018-2111-x}
}
MLA
Cite this
MLA Copy
Beloglazkina, A. А., et al. “Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction.” Russian Chemical Bulletin, vol. 67, no. 3, Mar. 2018, pp. 562-569. https://doi.org/10.1007/s11172-018-2111-x.